Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1999-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.96.18.10397PMID 10468619PMCID PMC17899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasopressin and urinary concentrating activity in diabetes mellitus.

  1999cited by this paper
• 5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors.

  1998cited by this paper
• Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

  1996cited by this paper
• Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action.

  1996cited by this paper
• Osmoregulation of Plasma Vasopressin in Diabetes Mellitus with Sustained Hyperglycemia

  1996cited by this paper
• Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors.

  1995cited by this paper
• Adaptation of the kidney to protein intake and to urine concentrating activity: similar consequences in health and CRF.

  1995cited by this paper
• Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

  1995cited by this paper
• Blood Pressure Control, Proteinuria, and the Progression of Renal Disease

  1995cited by this paper
• Down-regulation of vasopressin V1a receptor mRNA in diabetes mellitus in the rat.

  1995cited by this paper
• Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.

  1995cited by this paper
• Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.

  1994cited by this paper
• Vasopressin V1 and V2 receptors in diabetes mellitus.

  1994cited by this paper
• Is the process of urinary urea concentration responsible for a high glomerular filtration rate?

  1993cited by this paper
• Spontaneous Long-Term Hyperglycemic Rat With Diabetic Complications: Otsuka Long-Evans Tokushima Fatty (OLETF) Strain

  1992cited by this paper
• A critical role for central vasopressin in regulation of fever during bacterial infection.

  1992cited by this paper
• Central arginine vasopressin and endogenous antipyresis.

  1992cited by this paper
• The response of regulatory peptides to moderate hypoglycaemia of short duration in type 1 (insulin-dependent) diabetes mellitus and in normal man.

  1992cited by this paper
• Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system.

  1992cited by this paper
• Influence of the level of hydration on the renal response to a protein meal.

  1992cited by this paper
• Neuromuscular adaptations to cross-reinnervation in 12- and 29-mo-old Fischer 344 rats.

  1991cited by this paper
• Vasopressin is involved in renal effects of high-protein diet: study in homozygous Brattleboro rats.

  1991cited by this paper
• Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus.

  1991cited by this paper
• Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat.

  1990cited by this paper
• The effectiveness of arginine vasopressin and sodium salicylate as antipyretics in the Brattleboro rat.

  1990cited by this paper
• Diabetes mellitus in Brattleboro rats: cardiovascular, fluid, and electrolyte status.

  1989cited by this paper
• Vasopressin in Rats With Genetic and Streptozocin-Induced Diabetes

  1989cited by this paper
• Platelet Aggregation and Vasopressin Receptors in Patients with Diabetes Mellitus

  1988cited by this paper
• Effect of insulin on osmoregulation of vasopressin.

  1987cited by this paper
• Hormonal regulation of the tricarboxylic acid cycle in the isolated perfused rat liver.

  1986cited by this paper
• THE EFFECT OF VASOPRESSIN INFUSION ON GLUCOSE METABOLISM IN MAN

  1985cited by this paper
• Regulation of plasma vasopressin in insulin-dependent diabetes mellitus.

  1985cited by this paper
• The effect of arginine vasopressin on ureagenesis in isolated rat hepatocytes.

  1985cited by this paper
• Vasopressin promotes the metabolism of near-physiological concentration of glutamine in isolated rat liver cells

  1984cited by this paper
• Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats

  1984cited by this paper
• The effects of a chronic infusion of arginine vasopressin in salt-restricted, water-deprived man.

  1984cited by this paper
• Influence of vasopressin on renal hemodynamics in conscious Brattleboro rats.

  1984cited by this paper
• ABNORMALITY OF THE FEBRILE RESPONSE OF THE BRATTLEBORO RAT *

  1982cited by this paper
• Osmolal effects on vasopressin secretion in the streptozotocin-diabetic rat.

  1982cited by this paper
• Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics

  1981cited by this paper
• Glomerular hemodynamics in experimental diabetes mellitus.

  1981cited by this paper
• Convulsive and hypothermic effects of vasopressin in the brain of the rat.

  1980cited by this paper
• Plasma Vasopressin in Uncontrolled Diabetes Mellitus

  1979cited by this paper
• Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin.

  1979cited by this paper
• Renal and Electrolyte Disorders

  1976cited by this paper
• Hepatic action of vasopressin: Lack of a role for adenosine‐3′,5′‐cyclic monophosphate

  1974cited by this paper
• Increased Kidney Size and Glomerular Filtration Rate in Early Juvenile Diabetes

  1973cited by this paper
• Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver.

  1973cited by this paper
• LOWERING OF THE BODY TEMPERATURE INDUCED BY VASOPRESSIN

  1965cited by this paper
• FAMILIAL HYPOTHALAMIC DIABETES INSIPIDUS IN RATS (BRATTLEBORO STRAIN).

  1964cited by this paper

• Predictive role and clinical correlation of copeptin in patients with type 2 diabetes mellitus associated nephropathy approaching end-stage renal disease

  2026cites this paper
• Cardiorenal Syndrome in the Elderly: Challenges and Considerations

  2025cites this paper
• Overactive bladder phenotype induced by chronic activation of hypothalamic neuroendocrine stress pathways in rats with no extrinsic behavioral stress applied

  2025cites this paper
• Rethinking Vasopressin: New Insights into Vasopressin Signaling and Its Implications

  2023cites this paper
• Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease

  2023influential citation
• The effect of ellagic acid on the metabolic syndrome: A review article

  2023cites this paper
• Effect of Neurohypophyseal Hormones on Excretion of Proteins by the Kidneys

  2023cites this paper
• Effect of Neurohypophysial Hormones on Protein Excretion by the Kidneys

  2023cites this paper
• Kidney collecting duct cells make vasopressin in response to NaCl-induced hypertonicity

  2022cites this paper
• The vasopressin-aquaporin-2 pathway syndromes.

  2021cites this paper
• Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease

  2021cites this paper
• EVALUATION OF COPEPTIN HORMONE FUNCTION IN CHRONIC RENAL FAILURE STAGES AND DIALYSIS

  2021cites this paper
• Higher volume of water intake is associated with lower risk of albuminuria and chronic kidney disease

  2021cites this paper
• Water - A life-giving toxin - A nephrological oxymoron. Health consequences of water and sodium balance disorders. A review article.

  2021cites this paper
• Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease

  2021cites this paper
• Over-expression of arginine vasopressin in magnocellular neurosecretory cells of hypothalamus and its potential relationship with development of diabetic nephropathy

  2020cites this paper
• Association of Copeptin, a Surrogate Marker of Arginine Vasopressin, with Decreased Kidney Function in Sugarcane Workers in Guatemala

  2020cites this paper
• Upregulation of renal Na-K-2Cl cotransporter 2 in obese diabetes mellitus via a vasopressin receptor 2-dependent pathway.

  2020cites this paper
• Vasopressin actions in the kidney renin angiotensin system and its role in hypertension and renal disease.

  2020cites this paper
• Hydration for health hypothesis: a narrative review of supporting evidence

  2020cites this paper
• NOX4‐dependent regulation of ENaC in hypertension and diabetic kidney disease

  2020cites this paper
• Estimated plasma osmolarity and risk of end-stage kidney disease in patients with IgA nephropathy

  2020cites this paper
• The new biology of diabetic kidney disease - mechanisms and therapeutic implications.

  2020cites this paper
• Water Homeostasis in Chronic Kidney Disease

  2020cites this paper
• Renal response to an oral protein load in patients with central diabetes insipidus before and after treatment with vasopressin

  2019cites this paper
• Copeptin as a Biomarker of Atherosclerosis in Type 1 Diabetic Patients

  2019cites this paper
• Insulin Resistance and the Kidney in Youth

  2019cites this paper
• Antidiuretic hormone and serum osmolarity physiology and related outcomes: What is old, what is new and what is unknown?

  2019cites this paper
• Cardiorenal Syndrome: Pathophysiology.

  2019cites this paper
• The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes.

  2019cites this paper
• Long‐term ionic plasticity of GABAergic signalling in the hypothalamus

  2019cites this paper
• Vasopressin Increases Urinary Acidification via V1a Receptors in Collecting Duct Intercalated Cells.

  2019cites this paper
• Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population.

  2018cites this paper
• Water intake keeps type 2 diabetes away? Focus on copeptin

  2018cites this paper
• Vasopressin and Diabetic Kidney Disease

  2018cites this paper
• Plasma copeptin as a predictor of kidney disease

  2018cites this paper
• The Vasopressin System in the Risk of Diabetes and Cardiorenal Disease, and Hydration as a Potential Lifestyle Intervention

  2018cites this paper
• Diabetic Nephropathy in Children and Adolescents

  2018cites this paper
• Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank.

  2017influential citation
• Excitatory GABAergic Action and Increased Vasopressin Synthesis in Hypothalamic Magnocellular Neurosecretory Cells Underlie the High Plasma Level of Vasopressin in Diabetic Rats

  2017influential citation
• Vasopressin and diabetic nephropathy

  2017cites this paper
• Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders.

  2017cites this paper
• Regulation of renal Na-(K)-Cl cotransporters by vasopressin

  2017cites this paper
• Effects of exogenous desmopressin on a model of heat stress nephropathy in mice.

  2017cites this paper
• Vasopressin Mediates the Renal Damage Induced by Limited Fructose Rehydration in Recurrently Dehydrated Rats

  2017cites this paper
• Metabolic and Kidney Diseases in the Setting of Climate Change, Water Shortage, and Survival Factors.

  2016cites this paper
• Dehydration as a Cause of Chronic Kidney Disease: Role of Fructokinase

  2016cites this paper
• PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes

  2016cites this paper
• Heat Stress Nephropathy From Exercise-Induced Uric Acid Crystalluria: A Perspective on Mesoamerican Nephropathy.

  2016cites this paper
• Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence

  2016cites this paper
• Serum levels of copeptin are associated with type 2 diabetes and diabetic complications in Chinese population.

  2016cites this paper
• Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes.

  2016cites this paper
• Positive and negative aspects of cooperative action of angiotensin II and vasopressin in the kidney

  2016cites this paper
• Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies

  2016cites this paper
• Diet-sensitive prognostic markers for cardiovascular and renal disease

  2016cites this paper
• Impaired Renal Function

  2015cites this paper
• Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study

  2015cites this paper
• Daily fluid intake and outcomes in kidney recipients: post hoc analysis from the randomized ABCAN trial

  2015cites this paper
• Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats

  2015cites this paper
• Vasopressin receptor antagonists, heart failure, and polycystic kidney disease.

  2015cites this paper
• Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea.

  2015cites this paper
• Diabetes Complications in Childhood Diabetes: New Biomarkers and Technologies

  2015cites this paper
• 1 PROTEIN-AND DIABETES-INDUCED GLOMERULAR 2 HYPERFILTRATION : ROLE OF GLUCAGON , 3 VASOPRESSIN , AND UREA 4 5 6

  2015cites this paper
• A Review of the Nonpressor and Nonantidiuretic Actions of the Hormone Vasopressin

  2015cites this paper
• Vasopressin regulation of sodium transport in the distal nephron and collecting duct.

  2015cites this paper
• Hyperosmolarity drives hypertension and CKD—water and salt revisited

  2014cites this paper
• Early diabetic nephropathy in type 1 diabetes: new insights

  2014cites this paper
• Rôle de la vasopressine dans les troubles du métabolisme glucidique : possible impact dans le développement du diabète

  2014cites this paper
• Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: a population-based longitudinal cohort study.

  2014cites this paper
• Hydration and Kidney Health

  2014cites this paper
• Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)

  2013cites this paper
• Association between Water Intake, Chronic Kidney Disease, and Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data

  2013cites this paper
• Vasopressin: a novel target for the prevention and retardation of kidney disease?

  2013cites this paper
• Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria

  2013cites this paper
• Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)

  2013cites this paper
• Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort

  2013cites this paper
• Chronic activation of vasopressin V2 receptor signalling lowers renal medullary oxygen levels in rats

  2013cites this paper
• The medicinal use of water in renal disease.

  2013cites this paper
• Copeptin: May It Be a Novel Biomarker for Insulin Theraphy in Subjects with Diabetes?

  2013cites this paper
• Copeptin, a Surrogate Marker for Arginine Vasopressin,

  2013cites this paper
• Previous Exercise Training Has a Beneficial Effect on Renal and Cardiovascular Function in a Model of Diabetes

  2012cites this paper
• THE VASOPRESSIN SYSTEM IN DIABETES MELLITUS, OBESITY AND THE METABOLIC SYNDROME

  2012cites this paper
• The Role of Nitric Oxide in the Dysregulation of the Urine Concentration Mechanism in Diabetes Mellitus

  2012cites this paper
• Downregulation of vasopressin V1A receptors and activation of mitogen‐activated protein kinase in rat mesangial cells cultured under high‐glucose conditions

  2012cites this paper
• New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism.

  2012cites this paper
• cultured renal collecting duct principal cells Insulin potentiates AVP-induced AQP2 expression in

  2012cites this paper
• The effect of fluid intake on chronic kidney transplant failure: a pilot study.

  2011cites this paper
• Enhanced glucose tolerance in the Brattleboro rat.

  2011cites this paper
• The effect of dehydroepiandrosterone (DHEA) on renal function and metabolism in diabetic rats.

  2011cites this paper
• Potential Deleterious Effects of VP in CKD and Particularly ADPKD Kidney Blood

  2011cites this paper
• Potential Deleterious Effects of VP in CKD and Particularly ADPKD Kidney Blood

  2011cites this paper
• effect of dehydroepiandrosterone ( DHEA ) on renal function and metabolism n diabetic rats atheus

  2011cites this paper
• Potential Deleterious Effects of VP in CKD and Particularly ADPKD Kidney Blood

  2011cites this paper
• Potential Deleterious Effects of Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic Kidney Disease

  2011cites this paper
• Vasopressin beyond water: implications for renal diseases

  2010cites this paper
• [Diabetes mellitus: renal osmoregulating function].

  2010cites this paper
• Vasopressin in chronic kidney disease: an elephant in the room?

  2009cites this paper
• Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats

  2009cites this paper
• Molecular Biology and Gene Regulation of Vasopressin

  2009cites this paper
• Immunosenescence and Immunogenetics of Human Longevity

  2008cites this paper